Search
for

    Sort by

    Research 841–870 of 1000+

    1. Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial European Urology Supplements · 2019
    2. Additional file 4: of Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis Figshare · 2018
    3. Alopecia androgenética masculina de inicio precoz asociada a cáncer de próstata 2017
    4. Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele Cancer Causes & Control · 2017
    5. The Relationship between Androgenic Alopecia and Prostate Cancer International Journal of Medical Research and Health Sciences · 2016
    6. Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata 2015
    7. Prostate cancer risk and recurrence: the role of nutrition and clinical aspects 2013
    8. 343 RELATIONSHIP OF DIETARY INTAKE OF OMEGA-3 AND OMEGA-6 FATTY ACIDS WITH RISK OF PROSTATE CANCER DEVELOPMENT A META-ANALYSIS OF PROSPECTIVE STUDIES AND REVIEW OF LITERATURE The Journal of Urology · 2012
    9. 1451 THE ASSOCIATION BETWEEN MALE PATTERN BALDNESS AND SECOND TO FORTH FINGER RATIO WITH PROSTATE CANCER- A PROSPECTIVE COHORT STUDY The Journal of Urology · 2012
    10. 1449 PROSTATE CANCER PATIENTS WITH METABOLIC SYNDROME SHOWED LOW GRADE GLEASON SCORE WHEN DIAGNOSED ON BIOPSY The Journal of Urology · 2012
    11. Male pattern baldness linked to prostate problems Dermatology Times E-News · 2012
    12. Prostate cancer and androgenic alopecia Expert Review of Endocrinology & Metabolism · 2012
    13. S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION? European Urology Supplements · 2010
    14. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    15. 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA The Journal of Urology · 2010
    16. 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION The Journal of Urology · 2010
    17. S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8) European Urology Supplements · 2009
    18. Urological Oncology: Prostate Cancer The Journal of Urology · 2008
    19. Prostate cancer update: 2007 Current Opinion in Internal Medicine · 2008
    20. Body Mass Index is Associated with Increased Risk of aggressive and Decreased Risk of Non-aggressive Prostate Cancer American Journal of Epidemiology · 2006
    21. Prostate Specific Antigen Levels in Diabetic and Non-Diabetic Men from the 2001–2002 National Health and Nutrition Examination Survey American Journal of Epidemiology · 2006
    22. IMPLICAÇÕES DA TOMA CRÓNICA DA FINASTERIDE PARA A ALOPÉCIA ANDROGENÉTICA NO CARCINOMA DA PRÓSTATA Zenodo (CERN European Organization for Nuclear Research) · 2023
    23. Role of serum androgens and prostate-specific antigen levels in males with androgenetic alopecia Human Andrology · 2019
    24. Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia Journal of The American Academy of Dermatology · 2019
    25. P152 : Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia 프로그램북(구 초록집) · 2018
    26. Faculty Opinions recommendation of Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis. 2013
    27. 341 ANDROGENETIC ALOPECIA AT VARIOUS AGES AND PROSTATE CANCER RISK IN AN EQUAL ACCESS MULTIETHNIC CASE CONTROL SERIES OF VETERANS The Journal of Urology · 2012
    28. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003 · 1707 citations
    29. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor 2004 · 408 citations
    30. 5α-reductase activity in the prostate Urology · 2001 · 237 citations